(HealthDay News) – The majority of patients with current or recent Clostridium difficile infection (CDI) receive unnecessary antimicrobials, with 26% receiving only unnecessary antimicrobials, according to research published in the February issue of Infection Control and Hospital Epidemiology.
In an effort to examine unnecessary antimicrobial use, Megan K. Shaughnessy, MD, of the Minneapolis Veterans Affairs Health Care System, and colleagues performed a retrospective review of pharmacy and medical records for 246 patients diagnosed with new-onset CDI.
The researchers found that, during and/or after CDI treatment, 57% of patients with new-onset CDI received non-CDI antibiotics. More than three-quarters (77%) of all patients received one or more doses of unnecessary antimicrobials, and 26% received only unnecessary antimicrobials. Unnecessary antimicrobials were included in 45% of the total non-CDI antimicrobial days. The most commonly cited reasons for antimicrobial use included suspected pneumonia or urinary tract infection. Fluoroquinolones and β-lactam antibiotics were most often used.
“Non-CDI antimicrobials are often used unnecessarily in patients with a current or recent history of CDI,” the authors write. “This suggests that, during this window of heightened risk of CDI recurrence, a large portion of non-CDI antimicrobial use could be avoided, thereby presumably mitigating some of the associated recurrence risk.”
One author disclosed financial ties to the pharmaceutical industry.